Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific

The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer screening programs, especially in countries like Australia and South Korea. China and India will observe an increase in the uptake of GI endoscopy devices owing to growing physician and patient awareness, and the improving healthcare infrastructure. However, ASP declines due to price-based competition will continue to hamper some segments within the Asia Pacific GI endoscopy device market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Asia Pacific from 2019 through 2034.

The incorporation of AI has observed significant traction in this space. 

To what extent has AI been incorporated in the endoscopy process in the Asia Pacific region?

Which product segments will be affected the most over the forecast period?

Which competitors lead the market in terms of AI-assisted offerings?

The nationwide CRC and GI cancer screening programs are crucial for the growth of the GI endoscopy market.

How will countries with nationwide CRC and GI cancer screening programs differ in market growth in comparison to others?

Which geographies host a favorable regulatory environment for the growth of the GI endoscopy market?

Reusability and reprocessing processes remain a concern in the Asia Pacific region.

Which product and procedure segments are prone to contamination risks?

What clinical recommendations and guidelines have been issued by the regulatory bodies in the region?

What strategies have the competitors adopted to address these issues?

What are the latest innovations that could mitigate the risk of infection?

The Asia Pacific GI endoscopy device market is diverse, comprising both large international competitors and regional domestic manufacturers.

How much market share do MNCs hold in the Asia Pacific GI endoscopy market?

In which geographies is there strong domestic competition?

What strategies are domestic manufacturers employing to compete in the Asia Pacific GI endoscopy device market?

To what extent are domestic manufacturers penetrating their local markets?